PPARG and urinary bladder cancer: Taken together, though experimental studies showed promising anti-malignant effect of PPARγ agonists, due to the heterogeneity of this malignancy, more precise characterization on both genetic and epigenetic alterations in patients as well as cell lines is warranted to better understand the multifacet role of PPARγ in bladder cancer.